Exploring Psychedelic Therapies

20min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter examines the various uses of psychoactive substances, differentiating between clinical, ceremonial, and recreational contexts while considering their historical significance. It discusses the therapeutic roles of ketamine and psilocybin, highlighting their distinct experiences and implications for mental health treatment, especially in light of the post-pandemic landscape. Additionally, it addresses the importance of understanding individual factors in therapy and the ethical responsibilities of practitioners guiding clients through these altered states.

Could psychedelics revolutionize mental health care? Psychiatrist Dr. Will Van Derveer openingly discusses his exploration of psychedelic-assisted therapies after becoming disillusioned with conventional treatments.

He details remarkable results using ketamine, psilocybin, and MDMA for conditions like PTSD and depression. With the FDA's imminent decision on rescheduling MDMA, Van Derveer provides an inside look at these groundbreaking medicines' therapeutic potential. For those struggling with mental health issues, this candid conversation may reveal new hope.

You can find Will at: Website | Higher Practice Podcast | Episode Transcript

If you LOVED this episode you’ll also love the conversations we had with Adam Gazzaley about cutting-edge research he’s leading in this field.

Check out our offerings & partners: